12 public funds have seen a net asset value growth of over 10% this month, with oil and gas products outperforming innovative pharmaceutical themes.

Since June, the net value growth of oil and gas public funds has "overtaken" innovative pharmaceutical theme products. Data shows that as of June 18th, there were 12 public funds in the market with a net value growth of over 10% this month, with the top seven all being oil-themed funds. In addition, among the top twenty products in the list, oil and gas products account for the majority, while the previously well-performing innovative pharmaceutical funds have shown slightly weaker net value growth. Several analysts told reporters that due to significant international market fluctuations in June, assets such as oil and natural gas have shown strong price trends, leading to a higher net value growth for oil and gas funds. However, based on expectations for future supply and demand, it is feared that international oil prices may not have sustained support for further growth, so investors are advised to be cautious in holding related assets.